M. Woler

A new low molecular weight heparin derivative. In vitro and in vivo studies

J. Fourtillan, M. Aiach, A. Michaud, 1983 .

A new low molecular weight heparin fragment (PK 10169): in vitro and in vivo studies.

H. Vinazzer, M. Woler, 1985, Haemostasis.

The Antithrombotic Activity and Pharmacokinetics of Enoxaparine, A Low Molecular Weight Heparin, In Humans Given Single Subcutaneous Doses of 20 to 80 mg

M. Samama, A. Frydman, L. Bara, 1988, Journal of clinical pharmacology.

Administration of three cytokines instead of bone marrow transplantation in an HIV+ patient with high‐grade lymphoma

S. Lesage, A. Najman, N. Gorin, 1994, European journal of haematology.

Prevention of deep vein thrombosis in elderly medical in-patients by a low molecular weight heparin: a randomized double-blind trial.

C. Caulin, D. Houlbert, M. Woler, 1986, Haemostasis.

Efficacy of recombinant human erythropoietin in the treatment of refractory anemias without excess of blasts in myelodysplastic syndromes.

M. Labopin, P. Fenaux, B. Jaar, 1994, Leukemia & lymphoma.